Apyx Medical (APYX) Net Shares Issued and Repurchased (2010 - 2026)

Apyx Medical (APYX) has reported Net Shares Issued and Repurchased for 11 consecutive years, with $55000.0 the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Net Shares Issued and Repurchased fell 93.47% year-over-year to $55000.0; the trailing twelve-month figure through Mar 2026 stood at $55000.0 (down 93.47% YoY), and the FY2025 full-year result was $1.9 million, up 17.01% from the prior year.
• Net Shares Issued and Repurchased fell to $55000.0 in Q1 2026 per APYX's latest filing, from $1.9 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $1.9 million in Q4 2025 and bottomed at $55000.0 in Q1 2026.
• Historically, Net Shares Issued and Repurchased has averaged $1.2 million across 4 years, with a median of $1.5 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Net Shares Issued and Repurchased grew 17.01% in 2025, then sank 93.47% in 2026.
• Over 4 years, Net Shares Issued and Repurchased stood at $1.5 million in 2023, then climbed by 3.93% to $1.6 million in 2024, then increased by 17.01% to $1.9 million in 2025, then plunged by 97.04% to $55000.0 in 2026.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $55000.0, $1.9 million, and $842250.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.